Meeting
2013 Genitourinary Cancers Symposium
Patient benefit from salvage radiation for prostate cancer.
Authors
Brian Joseph Gebhardt
Medical College of Georgia, Augusta, GA
Brian Joseph Gebhardt , Andrew M. McDonald , Sejong Bae , Karan P. Singh , Rojymon Jacob , Michael C. Dobelbower , Robert Y. Kim , Eddy Shih-Hsin Yang , John B. Fiveash
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Prostate, Penile, Urethral, and Testicular Cancer, and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancer
Sub Track
Prostate Cancer
Citation
J Clin Oncol 31, 2013 (suppl 6; abstr 175)
DOI
10.1200/jco.2013.31.6_suppl.175
Abstract #
175
Poster Bd #
A8
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Salvage radiotherapy (SRT) in combination with pembrolizumab in patients with PSA persistence or biochemical recurrence after radical prostatectomy due to prostate cancer.
First Author: Markus Grabbert
Poster
2022 ASCO Genitourinary Cancers Symposium
Early initiation of salvage radiotherapy is associated with improved metastasis-free survival in patients with relapsed prostate cancer following prostatectomy.
First Author: Emerson Lee
Poster
2021 ASCO Annual Meeting
Validation of the decipher genomic classifier (GC) in SAKK 09/10: A phase III randomized trial of dose-escalated salvage radiotherapy (SRT) after radical prostatectomy (RP).
First Author: Alan Dal Pra
Poster
2017 Genitourinary Cancers Symposium
Prostate cancer specific mortality and overall survival outcomes for salvage radiation therapy after radical prostatectomy.
First Author: Shree Agrawal